# Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

> **NCT06705322** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 79 (estimated)

## Conditions studied

- Human Papillomavirus (HPV) Infection
- Cervical Cancer

## Interventions

- **DRUG:** Cnidium Monnieri Detoxification Formula

## Key facts

- **NCT ID:** NCT06705322
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2027-03-27
- **Final completion:** 2027-03-27
- **Target enrollment:** 79 (ESTIMATED)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06705322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06705322, "Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06705322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*